Association of a TGF-β1 gene −509 C/T polymorphism with breast cancer risk: a meta-analysis
- 146 Downloads
Transforming growth factor-β1 (TGF-β1) is negative regulator of cell proliferation and the cell cycle, and plasma levels of TGF-β1 are twice as high in TGF-β1 −509 T homozygotes as in −509 C homozygotes. Published studies on the association between the TGF-β1 gene −509 C/T polymorphism and breast cancer risk are inconclusive, and a meta-analysis is required to verify the association. We performed a meta-analysis of four studies, including a total of 5,986 cases and 6,829 controls. Our pooled results indicate that the TGF-β1 gene −509 C/T polymorphism is not associated with breast cancer risk in a TT versus CC codominant (OR = 1.08; 95% CI = 0.87–1.34; P = 0.494), in a CT versus CC codominant (OR = 1.02; 95% CI = 0.94–1.10; P = 0.686), recessive (OR = 0.92; 95% CI = 0.83–1.03; P = 0.157), and dominant (OR = 1.03; 95% CI = 0.96–1.11; P = 0.439) models. Conclusively, this meta-analysis suggests that the TGF-β1 gene −509 T allele polymorphism does not decrease breast cancer risk.
KeywordsTGF-β1 −509 C/T polymorphism Breast cancer risk Meta-analysis
- 4.Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV (1998) Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 66:1014–1020CrossRefPubMedGoogle Scholar
- 10.Dunning AM, Ellis PD, McBride S, Kirschenlohr HL, Healey CS, Kemp PR, Luben RN, Chang-Claude J, Mannermaa A, Kataja V, Pharoah PD, Easton DF, Ponder BA, Metcalfe JC (2003) A transforming growth factor beta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res 63:2610–2615PubMedGoogle Scholar
- 11.Jin Q, Hemminki K, Grzybowska E, Klaes R, Soderberg M, Zientek H, Rogozinska-Szczepka J, Utracka-Hutka B, Pamula J, Pekala W, Forsti A (2004) Polymorphisms and haplotype structures in genes for transforming growth factor beta1 and its receptors in familial and unselected breast cancers. Int J Cancer 112:94–99CrossRefPubMedGoogle Scholar